Thursday, March 19, 2026, 4:00 PM – Friday, March 20, 2026, 5:00 PM, Nationwide Children’s Hospital Conference Center, Columbus, OH
AMA PRA Category 1 Credits™ (6.75 hours), AAPA Credit(s) (6.75 hours), ACPE Contact Hour(s) (6.75 hours), ANCC Contact Hour(s) (6.75 hours), Non-Physician Attendance (6.75 hours)
This symposium will showcase state-of-the-art mechanistic insights and management strategies for kidney and urological complications in pediatric oncology. It will feature cutting-edge approaches and address gaps in early risk detection and timely intervention to improve cancer treatment tolerability, long-term outcomes, and quality of life
Target Audience: Physicians, providers, and researchers in nephrology, urology, pharmacology, oncology, hematology, and bone marrow transplant (BMT)
- Identify signs and characteristics of acute and long-term kidney and urological complications in pediatric patients with cancer
- Assess how cancer and anti-cancer therapies can result on kidney and urological complications
- Implement strategies that reduce the implications of kidney and urological complications on pediatric oncology patients’ care
- Identify emerging approaches to prevent or mitigate acute kidney injury and chronic kidney disease
- Analyze how anti-cancer therapies can be maximized by nephroprotective approaches
- Assess the impact of kidney complications and urological complications on patients and caregivers
- Strengthen interprofessional communication and collaboration among oncology, nephrology, urology, nursing, and allied health teams to ensure coordinated, patient-centered strategies for early detection, prevention, and management of kidney and urological complications in pediatric cancer care.
